At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 128 enrolled
Drug / intervention
Facial Moisturizer with SPF 50+drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Semi-occlusive Patch)
In Brief
A Phase 4 clinical trial evaluating Facial Moisturizer with SPF 50+ for Skin Irritation. Completed, enrolled 128 participants across 1 site.
Detailed Summary
This study examined the possible sensitization and irritation effects of a moisturizer with sunscreen SPF 50+.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Irritation
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2008
Primary CompletionMay 2008
Study CompletionAug 2008
First PostedJul 2013
TodayJul 2026
First PostedJul 4, 2013
Enrollment StartMar 1, 2008
Primary CompletionMay 1, 2008
Study CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 13.0 years ago
Interventions
Facial Moisturizer with SPF 50+drug
All subjects received applications of occlusive patches dosed with Cetaphil Daily Facial Moisturizer with SPF 50+